期刊文献+

磷酸钙骨水泥/骨形态蛋白人工骨复合骨髓基质细胞构建组织工程骨 被引量:1

Constructing tissue-engineered bone with calcium phosphate cement/bone morphogenetic protein artificial bone and bone marrow mesenchymal stem cells
下载PDF
导出
摘要 背景:体外实验证明磷酸钙骨水泥/骨形态蛋白人工骨具有较强的骨诱导作用,但是磷酸钙骨水泥/骨形态蛋白人工骨能否作为骨髓基质细胞的生长支架报道较少。目的:验证磷酸钙骨水泥/骨形态蛋白人工骨做为骨组织工程支架材料的可行性。设计、时间及地点:观察实验,于2008-03/2009-03在上海市第九人民医院口腔组织工程实验室完成。材料:磷酸钙骨水泥/骨形态蛋白人工骨产品由瑞邦公司提供,大孔径200~500μm,小孔径1~5μm,孔隙率为70%。两岁的健康毕格犬1只。方法:抽取成年毕格犬的骨髓,贴壁法获得骨髓基质细胞,经成骨诱导培养液体外培养、扩增、诱导后观察细胞增殖情况。将培养的第2代细胞接种于多孔型活性磷酸钙骨水泥,进行超微结构观察,并将多孔型活性磷酸钙骨水泥/骨髓基质细胞复合物植入毕格犬背部皮下,2,4周后进行组织学检测。主要观察指标:倒置相差纤维镜下观察细胞的生长、增殖情况;碱性磷酸酶染色、Von Kossa染色、骨钙素免疫细胞化学染色鉴定骨细胞的形成标志;扫描电镜观察细胞材料复合情况;苏木精-伊红染色观察体内异位成骨情况。结果:碱性磷酸酶染色呈阳性;Von Kossa染色可见钙结节形成;骨钙素免疫细胞化学染色呈阳性;超微结构观察可见细胞生长附着于材料网孔内表面;组织学检测提示4周时复合物内有新骨形成。结论:多孔型活性磷酸钙骨水泥/骨髓基质细胞复合物显示良好的成骨活性,磷酸钙骨水泥/骨形态蛋白人工骨可以用于骨组织工程支架材料。 BACKGROUND: In vitro studies have shown that calcium phosphate cement/bone morphogenetic protein artificial bone has strong bone induction effects, but whether calcium phosphate cement/bone morphogenetic protein artificial bone can be used as growth stent of bone marrow stromal cells (BMSCs) is still unknown. OBJECTIVE: To study the probability of calcium phosphate cement/bone morphogenetic protein artificial bone that be used as a scaffold for bone tissue engineering. DESIGN, TIME AND SETTING: This observational study was performed at the Lab of Stomatology and Tissue Engineering, Shanghai Ninth People's Hospital from March, 2008 to March, 2009. MATERIALS: Calcium phosphate cement/bone morphogenetic protein artificial bone was supplied by Ruibang Company, with big aperture of 200-500 μm, small aperture of 1~5μ m, and porosity rate of 70%. A healthy beagle dog of two years old was used in this study. METHODS: After drawing out the bone marrow from the Beagle Dog, the BMSCs were separated by adherent methods, and induced with the conditional medium, in vitro cultured, amplified. Cell proliferation was observed following induction. The induced passage 2 cells were mixed to active calcium phosphate cement form a complex. Ultrastructure was observed. The complex was implanted into the subcutaneous parts of the beagle dog. Histological observation were taken after 2 and 4 weeks. MAIN OUTCOME MEASURES: The growth and proliferation of BMSCs were observed with inverted contrast phase microscope. The alkaline phosphatase staining, Von Kossa staining, Osteocalsin immunocytochemical staining were applied to identify the bone cells. The adherence of cells and active calcium phosphate cement was observed with scanning electron microscope. Hematoxylimeosin staining was applied to observe the bone. RESULTS: Alkaline phosphatase staining was positive. Von Kossa staining proofed the formation of mineralization nodules. Immunocytochemical staining showed the expression of osteocalcin. Scanning electron micrograph showed the cells adhered to the inner surface of the active calcium phosphate cement. Hematoxylin-eosin staining showed the new bone formation. CONCLUSION: Complex (active calcium phosphate cement/BMSCs incubated in vitro) showed new bone formation. The calcium phosphate cement/bone morphogenetic protein artificial bone can be used as a scaffold for bone tissue engineering.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第21期4059-4063,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献23

  • 1中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 2Beresford JN,Bennett JH,Devlin C,et al.Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures.J Cell Sci.1992;102(Pt 2):341-351.
  • 3Wang EA,Rosen V,D'Alessandro JS,et al.Recombinant human bone morphogenetic protein induces bone formation.Proc Natl Acad Sci U S A.1990:87(6):2220-2224.
  • 4Wang JC,Kanim LE,Yoo S,et al.Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.J Bone Joint Surg Am.2003;85-A(5):905-911.
  • 5El-Amin SF,Lu HH,Khan Y,et al.Extracellular matrix production by human osteoblasts cultured on biodeqradable polymers applicable for tissue engineering.Biomaterials.2003;24(7):1213-1221.
  • 6韦永中,范卫民,王道新.自固化磷酸钙复合兔自体骨髓基质细胞和bFGF异位成骨的研究[J].南京医科大学学报(自然科学版),2004,24(5):511-514. 被引量:4
  • 7Huang W,Carisen B.Wulur I,et al.BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold..Exp Cell Res.2004:299(2):325-334.
  • 8Ginebra M P,Traykova T,Planell JA.Calcium phosphate cements:competitive drug carriers for the musculoskeletal system?Biomaterials.2006;27(10):2171-2177.
  • 9Nakano M,Hirano N,lshihara H,et al.Calcium phosphate cement-based vertebroplasty compared with conservative treatment for osteoporotic compression fractures:a matched case-control study.J Neurosurg Spine.2006;4(2):110-117.
  • 10Seeherman H,Li R,Bouxsein M,et al.rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations.J Bone Joint Surg Am.2006;88(1):144-160.

二级参考文献20

  • 1吴子祥,胡蕴玉,雷伟,李丹,万世勇,王海强,李波,付索超.bBMP复合纤维蛋白胶治疗绵羊脊柱骨质疏松的实验研究[J].中国骨质疏松杂志,2007,13(6):410-413. 被引量:4
  • 2Zimmermann R, Gabl M, Lutz M, et al. Injectable calcium phosphate bone cement Norian SRS for the treatment of intra-articular compression fractures of the distal radius in osteoporotic women. Arch Orthop Trauma Surg, 2003,123(1):22-27.
  • 3Nakano M, Hirano N, Ishihara H, et al. Calcium phosphate cementbased vertebroplasty compared with conservative treatment for osteoporotic compression fractures: a matched case-control study. J Neurosurg Spine,2006,4(2) : 110-117.
  • 4Seeherman H, Li R, Bouxsein M, et al. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am, 2006,88(1) : 144-160.
  • 5Phillips FM, Turner AS, Seim HB 3rd, et al. In vivo BMP-7 (OP- 1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J,2006,6(5) :500-506.
  • 6Styrkarsdottir U, Cazier JB, Kong A, et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol, 2003,1 (3) :E69.
  • 7Turgeman G, Zilberman Y, Zhou S, et al. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem,2002,86:461-474.
  • 8Jansen JA, Vehof JW, Ruhe PQ, et al. Growth factor-loaded scaffolds for bone engineering. J Control Release, 2005,101 (1-3) : 127-136.
  • 9Wang ML, Massie J, Perry A, et al. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements. Spine J, 2007,7 (4) :466-474.
  • 10Hong SJ, Park YK, Kim JH, et al. The biomechanical evaluation of calcium phosphate cements for use in vertebroplasty. J Neurosurg Spine, 2006,4(2) : 154-159.

共引文献710

同被引文献12

  • 1袁捷,殷德民,王敏,许锋,崔磊,刘伟,曹谊林.犬骨髓基质干细胞复合珊瑚羟基磷灰石皮下成骨的实验研究[J].中国口腔颌面外科杂志,2005,3(3):207-211. 被引量:9
  • 2曹雪华,刘昌胜,陈建国.多孔磷酸钙人工骨与重组人骨形成蛋白2复合修复骨缺损的实验研究[J].中国修复重建外科杂志,2006,20(9):916-919. 被引量:19
  • 3Habraken WJ,de Jonge LT,Wolke JG, et al. Introduction of gelatin microspheres into an injectable calcium phosphate cement [J]. J Biomed Mater Res A,2008,87(3):643-655.
  • 4Pek YS, Kurisawa M, Gao S, et al. The development of a nanocrystalline apatite reinforced crosslinked hyaluronic acid- tyramine composite as an injectable bone cement[J]. Biomaterials, 2009,30(5):822-828.
  • 5Wang CK, Ho ML, Wang GJ, et al.Controlled-release of rhBMP- 2 carriers in the regeneration of osteonecrotic bone [J]. Biomaterials,2009,30(25):4178-4186.
  • 6Sogabe Y, Abe M, Yokoyama Y, et al. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation[J]. Wound Repair Regen,2006,14(4):457-462.
  • 7Miks AG, Temenoff JS. Formation of highly porous biodegradable scaffolds for tissue engineering[J].Electron J Biotechnol,2000,3(2): 114-119.
  • 8Kroese-Deutman HC, Ruhe PQ, Spauwen PH, et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits[J]. Biomateria-Is,2005,26:1131 - 1138.
  • 9Wang L, Huang Y, Pan K, et al. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation[J]. Ann Biomed Eng,2009,38(1):77-87.
  • 10Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery [J].Gene Ther,2004,11 (17): 1312-1320.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部